Pluristem Therapeutic Revenue Quarterly YoY Growth:
-15.58% for Dec. 31, 2012Pluristem Therapeutic Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -15.58% |
| Sept. 30, 2012 | 26.62% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
PSTI Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| United Therapeutics Corporation | 20.04% |
| BioTime | -25.98% |
| Neuralstem | -99.13% |
PSTI Revenue Quarterly YoY Growth Rankings
| Overall |
44th percentile 4221 of 7590 |
| Sector |
35th percentile 417 of 651 in Healthcare |
| Industry |
57th percentile 100 of 238 in Biotechnology |
PSTI Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -15.58% | Dec 2012 |
| Maximum | 26.62% | Sep 2012 |
| Average | 5.52% |
